Cost-effectiveness of catheter ablation treatment for patients with symptomatic atrial fibrillation

Journal of Atrial Fibrillation

Volumn 1, Issue 8, 2009, Pages 461-470

  Eckard, Nathalie ^a   Davidson, Thomas ^a   Walfridsson, Håkan ^b   Levin, Lars Åke ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Ablation; Atrial fibrillation; Cardiovascular disease; Cost; Cost effectiveness; Decision analytic model

Indexed keywords

ANTIARRHYTHMIC AGENT; WARFARIN;

CATHETER ABLATION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG USE; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HUMAN; OUTCOME ASSESSMENT; PROBABILITY; PULMONARY VEIN; QUALITY ADJUSTED LIFE YEAR; REVIEW; STATISTICAL MODEL; STROKE;

EID: 77952313801     PISSN: None     EISSN: 19416911     Source Type: Journal    
DOI: 10.4022/jafib.v1i8.543     Document Type: Review

References (24)

1. Reynolds MW, Fahrbach K, Hauch O, Wygant G, Estok R, Cella C, et al., Warfarin anticoagulation and outcomes in patients with atrial fibrillation: A systematic review and metaanalysis. Chest, 2004, 126: 1938-1945.
2. Khaykin Y, Morillo CA, Skanes AC, McCracken A, Humphries K, Kerr CR, Cost Comparison of Catheter Ablation and Medical Therapy in Atrial Fibrillation, J Cardiovasc Electrophysiol, 2007, 18: 907-913. (Pubitemid 47342400)
3. Khaykin Y, Wang X, Natale A, Wazni OM, Skanes AC, Humphries KH, et al., Cost Comparison of Ablation Versus Antiarrhythmic Drugs as First-Line Therapy for Atrial Fibrillation: An Economic Evaluation of the RAAFT Pilot Study, J Cardiovasc Electrophysiol, 2009, 20: 7-12.
4. Chan PS, Vijan S, Morady F, Oral H, Cost-Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation, Journal of the American College of Cardiology, 2006, 47; 12: 2513-2520. (Pubitemid 43866357)
5. McKenna C, Palmer S, Rodgers M, Chambers D, Hawkins N, Golder S, et al., Cost-effectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the United Kingdom, Heart, 2009, 95: 542-549.
6. Swedish National Guidelines for Heart Disease 2008. The National Board of Health and Welfare. Socialstyrelsens riktlinjer för hjärtsjukvå rd 2008. Beslutsstöd för prioriteringar, Socialstyrelsen.
7. Pappone C, Oreto G, Lamberti F, Vicedomini G, Lorricchio ML, Shpun S, et al., Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system, Circulation, 1999, 100: 1203-1208. (Pubitemid 29426596)
8. Khaykin Y, Cost-effectiveness of catheter ablation for atrial fibrillation, Cardiology, 2007, 22: 11-17. (Pubitemid 44913867)
9. Krittayaphong R, Raungrattanaamporn O, Bhuripanyo K, Sriratanasathavorn C, Pooranawattanakul s, Punlee K, et al., A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation, J Med Assoc Thai, 2003, 86; 1: S8-16. (Pubitemid 36909283)
10. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, et al., Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation. A randomized trial, JAMA 2005, 293; 21: 2634-2640. (Pubitemid 40744248)
11. Stabile G, Bertaglia E, Senatore G, De Simone A, Zoppo F, Donnici G, et al., Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective multi-centre, randomized, controlled study (Catheter ablation for the cure of atrial fibrillation study), European Heart Journal 2006; 27: 216-221. (Pubitemid 43069040)
12. Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, et al., A Randomized Trial of Circumferential Pulmonary Vein Ablation Versus Antiarrhythmic Drug Therapy in Paroxysmal Atrial Fibrillation. The APAF Study, Journal of the American College of Cardiology, 2006, 48; 11, 2340-2347. (Pubitemid 44856763)
13. Jais P, Cauchmez B, Macle L, Daoud E, Khairy P, Subbiah R et al., Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: The A4 Study, Circulation, 2008, 118: 2498-2505.
14. Department of Cardiology, Linköping University Hospital, Sweden, 2001-2008.
15. Statistics Sweden. Life Tables. 2008. http://www.scb.se/ statistik/BE/BE0101/2006MO2/be0101Livslängdstabeller eng. xls (accessed 28 Feb 2008).
16. Samverkansnämnden Sydöstra sjukvårdsregionen. Prislista år 2005. http://www.lio.se/upload/16047/Prislista 2005 (accessed 28 Aug 2008).
17. SBU Alert, Kateterburen ablationsbehandling vid förmaksflimmer, SBU ALERT-Rapport nr 2005-2102, 2005.
18. Cappato R, Calkins H, Chen S-A, Davies W, Iesaka Y, Kalman J, et al., Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation, Circulation, 2005, 111: 1100-1105.
19. Swedish national catheter ablation register, 2007.
20. Weerasooriya, R, Jais P, Le Heuzy J-Y, Scavée C, Choi K-J, Macle L, et al., Cost analysis of catheter ablation for paroxysmal atrial fibrillation, PACE, 2003; 26: 292-294. (Pubitemid 36399158)
21. Davidson T, Levin L-Å, Kostnaden för förmaksflimmer i Östergötland, CMT-rapport, 2006:5, Linköpings universitet, 2006.
22. Ghatnekar O, Persson U, Glader E-L, Terént A. Cost of stroke in Sweden: An incidence estimate. International Journal of Technology Assessment in Health Care, 2004, 20; 3: 375-380. (Pubitemid 39079575)
23. Weerasooriya, R, Jais P, Hocini M, Scavée C, Macle L, Hsu LF, et al., Effect of catheter ablation on quality of life of patients with paroxysmal atrial fibrillation, Heart Rhythm, 2005, 2: 619-623. (Pubitemid 40724129)
24. Burström K, Rhenberg C, Hälsorelaterad livskvalitet i Stockholms län 2002. Resultat per åldergrupp och kön, utbildningsnivå, födelseland samt sysselsättningsgrupp - en befolkningsundersökning med EQ-5D. Centrum för folkhälsa. Enheten för Socialmedicin och Hälsoekonomi. Rapport 2006:1.